GlassScriptPhysician profile
Cassidy Douglas Mitchell
NPI 1508858432
$1,650.57
in general payments reported to CMS, 2019-2025
9 companies · $40.78 in 2025
The $40.78 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.72 · 2020: $14.09 · 2021: $161 · 2022: $1,076 · 2023: $275 · 2024: $40.57 · 2025: $40.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $275 · Food and Beverage: $81.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $275.00 |
| Food and Beverage | $81.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,091.43 | 2021-2022 | |
| Johnson & Johnson Health Care Systems INC. | $275.00 | 2023 | |
| Rti Surgical, INC | $124.67 | 2022 | |
| Integra Lifesciences Corporation | $40.78 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $40.57 | 2024 | Anchorage |
| Mentor Worldwide LLC | $29.65 | 2019 | |
| Boston Scientific Corporation | $21.31 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.09 | 2020 | |
| Galderma Laboratories, L.P. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassidy Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.